I. Obdeijn

发表

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

H. D. de Koning, J. Klijn, R. Tollenaar, 2004, The New England journal of medicine.

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition

Harry J de Koning, Mieke Kriege, Carla Boetes, 2006, Cancer.

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI

R. Mann, C. Boetes, I. Obdeijn, 2008, European Radiology.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jaana M. Hartikainen, W. Chung, 2019, Nature Genetics.

First experiences in screening women at high risk for breast cancer with MR imaging

Matthijs Oudkerk, Harry J. de Koning, H. D. de Koning, 2000, Breast Cancer Research and Treatment.

An ultrasound cylindrical phased array for deep heating in the breast: theoretical design using heterogeneous models

J F Bakker, G C van Rhoon, K W A van Dongen, 2009, Physics in medicine and biology.

MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast.

M Oudkerk, M. Oudkerk, I. Obdeijn, 2000, AJR. American journal of roentgenology.

Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis.

Harry J de Koning, Madeleine M A Tilanus-Linthorst, Ellen Warner, 2017, European journal of cancer.

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

H. D. de Koning, E. Heijnsdijk, C. Seynaeve, 2012, BMC Cancer.

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.

Harry J de Koning, Madeleine M A Tilanus-Linthorst, Mieke Kriege, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition

Claudette E. Loo, Carla Boetes, Martin N. J. M. Wasser, 2009, Breast Cancer Research and Treatment.

A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false‐negative mammography

Theo van der Kwast, T. H. van der Kwast, J. Klijn, 2002, International journal of cancer.

Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: a critical review of the literature.

S. Sleijfer, M. Hooning, A. Jager, 2015, Cancer treatment reviews.

Efficacy of magnetic resonance imaging and mammography for breast cancer screening in women with a familial or genetic predisposition

J. Klijn, R. Tollenaar, H. Peterse, 2005 .

Breast fine‐needle aspiration cytology performance in the high‐risk screening population

M. Hooning, A. Jager, C. V. van Deurzen, 2013, Cancer cytopathology.

Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study

M. Schmidt, M. Hooning, A. Jager, 2022, Breast Cancer Research and Treatment.

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.

J. Klijn, C. Seynaeve, A. V. D. van den Ouweland, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study

M. Hooning, R. Mann, M. Hunink, 2014, Breast Cancer Research and Treatment.

Radioactive Seed Versus Wire-Guided Localization for Ductal Carcinoma in Situ of the Breast: Comparable Resection Margins

L. Koppert, C. V. van Deurzen, I. Obdeijn, 2020, Annals of Surgical Oncology.

Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis.

M. Greuter, N. Houssami, I. Obdeijn, 2019, Breast.

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

A. Whittemore, L. Kiemeney, S. Cross, 2016, Nature Communications.

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy

M. Schmidt, M. Hooning, C. Seynaeve, 2014, Cancer biology & therapy.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2019, Nature Genetics.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2021, Nature Communications.

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)

H. D. de Koning, E. Heijnsdijk, M. Hooning, 2015, International journal of cancer.

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.

N. Karssemeijer, H. D. de Koning, R. Tollenaar, 2019, The Lancet. Oncology.

Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models.

H. D. de Koning, E. Heijnsdijk, I. Obdeijn, 2016, European journal of cancer.

Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer

H. D. de Koning, J. Klijn, R. Tollenaar, 2006, Breast Cancer Research and Treatment.

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study

A. Jager, L. Koppert, C. V. van Deurzen, 2016, Breast Cancer Research and Treatment.

Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure.

T. H. van der Kwast, T. Kwast, M. Menke-Pluymers, 2003, European journal of cancer.

Breast MRI in high risk patients

I. Obdeijn, 2015 .

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.

H. D. de Koning, R. Tollenaar, E. Heijnsdijk, 2013, Journal of the National Cancer Institute.

BRCA1 Mutation and Young Age Predict Fast Breast Cancer Growth in the Dutch, United Kingdom, and Canadian Magnetic Resonance Imaging Screening Trials

R. Warren, J. Klijn, W. Hop, 2007, Clinical Cancer Research.

Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis.

E. R. van den Heuvel, H. D. de Koning, T. Helbich, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Benefits of preoperative MRI in breast cancer surgery studied in a large population‐based cancer registry

L. Koppert, S. Siesling, I. Obdeijn, 2015, The British journal of surgery.

Magnetic resonance imaging before breast cancer surgery: results of an observational multicenter international prospective analysis (MIPA)

E. Wenkel, P. Bult, T. Helbich, 2021, European Radiology.

Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk

H. D. de Koning, E. Heijnsdijk, I. Obdeijn, 2021, Breast.

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.

H. D. de Koning, R. Tollenaar, E. Heijnsdijk, 2020, JAMA oncology.

Preoperative prediction of cosmetic results in breast conserving surgery

L. Koppert, I. Obdeijn, C. Verhoef, 2015, Journal of surgical oncology.

Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis.

M. Hooning, A. Jager, C. Seynaeve, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.